Jasper Littmann
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 10
-
- Ethics in Clinical Research 3
- Co-authors
- Otto Cars (2 shared papers)A. M. Viens (2 shared papers)Anna Zorzet (1 shared paper)Alena Buyx (5 shared papers)Norio Ohmagari (2 shared papers)Didier Wernli (2 shared papers)Annette Rid (2 shared papers)Keiji Fukuda (2 shared papers)
- Journals
- Public Health Ethics (3 papers)BMJ Global Health (1 paper)Upsala Journal of Medical Sciences (1 paper)Bioethics (1 paper)Research Ethics (1 paper)
- Partner nations
- GermanyNorwayUnited States
In The Last Decade
Jasper Littmann
20 papers receiving 583 citations
Peers
Comparison fields: 5 of 117
- Applied Microbiology and Biotechnology 264
- Molecular Medicine 151
- Pollution 109
- Geriatrics and Gerontology 16
- Clinical Biochemistry 30
Countries citing papers authored by Jasper Littmann
This map shows the geographic impact of Jasper Littmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasper Littmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasper Littmann more than expected).
Fields of papers citing papers by Jasper Littmann
This network shows the impact of papers produced by Jasper Littmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasper Littmann. The network helps show where Jasper Littmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Jasper Littmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 275 | |
| 2 | 2015 | 105 | |
| 3 | 2015 | 65 | |
| 4 | 2015 | 61 | |
| 5 | 2020 | 40 | |
| 6 | 2017 | 10 | |
| 7 | 2019 | 8 | |
| 8 | 2019 | 6 | |
| 9 | Evaluation of the EC Action Plan Against the Rising Threats from Antimicrobial Resistance | 2016 | 6 |
| 10 | 2022 | 5 | |
| 11 | 2024 | 4 | |
| 12 | 2019 | 4 | |
| 13 | 2016 | 4 | |
| 14 | 2014 | 4 | |
| 15 | 2024 | 2 | |
| 16 | 2014 | 2 | |
| 17 | Evaluation of the EC Action Plan Against the Rising Threats from Antimicrobial Resistance: Final Report | 2016 | 2 |
| 18 | 2011 | 1 | |
| 19 | 2023 | 1 | |
| 20 | 2018 | 1 |
About Jasper Littmann
Jasper Littmann is a scholar working on Applied Microbiology and Biotechnology, Public Health, Environmental and Occupational Health, Infectious Diseases, Pediatrics, Perinatology and Child Health and Molecular Medicine, having authored 21 papers that have together received 607 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (10 papers), Global Maternal and Child Health (3 papers), Antibiotic Resistance in Bacteria (3 papers), Ethics in Clinical Research (3 papers), Pharmaceutical Economics and Policy (2 papers), Complementary and Alternative Medicine Studies (2 papers), Vaccine Coverage and Hesitancy (2 papers) and Health Policy Implementation Science (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (264 citations), Molecular Medicine (151 citations), Pollution (109 citations), Geriatrics and Gerontology (16 citations) and Clinical Biochemistry (30 citations). Jasper Littmann has collaborated with scholars based in Germany, Norway and United States. Frequent co-authors include Otto Cars, A. M. Viens, Anna Zorzet, Alena Buyx, Norio Ohmagari, Didier Wernli, Annette Rid, Keiji Fukuda, Ping Liu and Nobuaki Matsunaga. Their work appears in journals such as Public Health Ethics, BMJ Global Health, Upsala Journal of Medical Sciences, Bioethics and Research Ethics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.